Icon

INDERAL (nda016418)- (10MG,20MG,40MG,60MG,80MG,90MG)

PROPRANOLOL HYDROCHLORIDE WYETH PHARMS
10MG,20MG,40MG,60MG,80MG,90MG
No No
Expired Expired
None None
None No
Inderal is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Inderal is indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Inderal is indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Inderal is indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. Inderal is indicated for the prophylaxis of common migraine headache. Inderal is indicated in the management of familial or hereditary essential tremor consisting involuntary, rhythmic, oscillatory movements, usually limited to the upper limbs. Inderal improves NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis. Inderal is indicated as an adjunct to alpha-adrenergic blockade to control blood pressure and reduce symptoms of catecholamine-secreting tumors.
12 0 11
Total Other Developers 2
Drugs with Suitability No
10MG ** ** - 5 1
20MG ** ** - - 6
40MG ** ** - - 6
60MG ** ** - - 5
80MG ** ** - - 6
90MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ***** **** ** ***. *********** ** *** ****** **** ********** ****, *** **, ******, ****** **** (**) *****, ****** ****** (***) ***
****** **** ********** *** ************ ******* ******* *********** */***, **********-******** **** ****, **********, ***********,,, *******, ***** **** ******, ***** (***) ***
****** ********* *********, ***. *********** **** *** ******** ****, **********, *** **** (**) *****, ****** ****** (***) ***
****** ***** **** *** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** **** **** *** **** ************ ******* *********** **** **. **, ** *** ***, ******** ********** ******, *******, ********, *.*. ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ****** **** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ***** **** *** ****** ******* ******** ******** *** *********** *** ** ******* ***/***, ***********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** **** *** ****** *************** ******* ******* *********** **** **. **,**,** ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ******* ******, ***** (***) ***
****** ****** **** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ********* *********, ***. *********** **** *** ******** ****, **********, *** **** (**) *****, ****** ****** (***) ***
****** ***** **** *** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ****** **** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.